Calponin is an actin binding, troponin-like molecule, first isolated from chicken gizzard smooth muscle cells where it is involved in regulation of contractility. So far there are three known isoforms, basic, acidic and neutral Calponin, each encoded by a separate gene. Expression of the acidic Calponin isoform is, unlike basic Calponin, not restricted to smooth muscle cells but is expressed in a variety of tissues and cell types, especially in the brain. For basic Calponin it is known that the molecule affects smooth muscle cell contractility by regulation of the PKC/ERK signaling pathway. Here we could show that acidic Calponin co-precipitates together with ERK1/2 and PKCalpha in the cultured rat fibroblast cell line REF52.2. Moreover it colocalises with ERK1/2 and PKCalpha in podosome-like structures and at the cell cortex after Phorbol-12,13-Dibutyrate (PDBu) treatment. Knockdown of acidic Calponin expression in these cells results in inhibition of PDBu-mediated ERK1/2 translocation to these structures, whereas PKCalpha targeting is not affected. Both endogenous ERK1/2 activity and phosphorylation of the ERK1/2 substrate l-Caldesmon are blocked by acidic Calponin knockdown, indicating an important role for the acidic Calponin isoform in regulation of ERK1/2 function in REF52.2 cells.Abstract sponsored by John Gergely, Boston Biomedical Research Institute, Watertown 02472, MA, USASupport: NIH grants HL80003, HL86655